- Conditions
- Injection Site Irritation, Injection Site Bruising, Injection Site Discomfort, Benzoic Acid Adverse Reaction, Anesthesia, Local
- Interventions
- Sodium Chloride 0.9% Inj, Bacteriostatic Sodium Chloride 0.9 % INJECTION VIAL (ML)
- Drug
- Lead sponsor
- Jeffrey Alan Klein, MD
- Industry
- Eligibility
- 16 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- San Juan Capistrano, California
Source: ClinicalTrials.gov public record
Updated Nov 4, 2021 · Synced May 22, 2026, 1:39 AM EDT